印疫苗商:加強劑可產Omicron/Delta抗體
印度疫苗製造商Bharat Biotech開發的新冠疫苗 Covaxin   AFP VIA GETTY IMAGES

印疫苗商:加強劑可產Omicron/Delta抗體

患者血清樣本研究指出,加強劑有降低重症率和住院治療的可能性
Sign in to get access

We're glad you're enjoying ForbesGA - Forbes Global Alliance. Sign in to continue reading this story.

新聞推薦

No stories found.
ForbesGA - Forbes Global Alliance
www.forbesga.com